Tom Hudson retires from AbbVie after eight years with the company.
AbbVie CSO Tom Hudson to retire, replaced by medical chief
A day after Pfizer disclosed the departure of its longtime chief scientific officer, AbbVie is doing the same,
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
